Wayne Shaw

机构：Johnson & Johnson (United States)

发表论文 52 篇 · 总被引 12022 次 · h-index 27

代表论文

• Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials (2018 · The Lancet Diabetes & Endocrinology · 被引 647)
• Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events (2017 · Circulation · 被引 507)
• Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus (2018 · Circulation · 被引 490)
• Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus (2019 · Circulation · 被引 164)
• Mediators of the Effects of Canagliflozin on Heart Failure in Patients With Type 2 Diabetes (2019 · JACC Heart Failure · 被引 143)
• Effects of Canagliflozin on Amino-Terminal Pro–B-Type Natriuretic Peptide (2020 · Journal of the American College of Cardiology · 被引 100)